Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Share News (OXB)

Share Price Information for Oxford Biomedica (OXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 335.00
Bid: 336.50
Ask: 338.50
Change: 19.00 (6.01%)
Spread: 2.00 (0.594%)
Open: 319.50
High: 341.00
Low: 319.50
Prev. Close: 316.00
OXB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

24 Jun 2020 15:21

DIRECTOR DEALINGS: Oxford BioMedica Non-Exec Sells GBP1.8 Million

DIRECTOR DEALINGS: Oxford BioMedica Non-Exec Sells GBP1.8 Million

Read more
19 Jun 2020 14:40

IN BRIEF: Oxford Biomedica Raises GBP40 Million To Fund Investments

IN BRIEF: Oxford Biomedica Raises GBP40 Million To Fund Investments

Read more
18 Jun 2020 18:26

Oxford Biomedica Seeks To Raise GBP40 Million Via Share Placing

Oxford Biomedica Seeks To Raise GBP40 Million Via Share Placing

Read more
8 Jun 2020 17:12

Oxford Biomedica Says Sanofi To Return Rights To Two Programmes

Oxford Biomedica Says Sanofi To Return Rights To Two Programmes

Read more
8 Jun 2020 11:54

UK TRADING UPDATE SUMMARY: Oxford Biomedica Works On Covid-19 Vaccine

UK TRADING UPDATE SUMMARY: Oxford Biomedica Works On Covid-19 Vaccine

Read more
8 Jun 2020 09:41

UPDATE 2-UK stocks end lower on concerns over corporate debt; AstraZeneca weighs

* AstraZeneca slips on report of potential merger with Gilead* Plus500 falls after big revenue hit from client trading wins* Oil & gas stocks gain after OPEC production cuts* BP rises after report of job cuts (Adds details, updates to close)By Shr...

Read more
3 Jun 2020 17:28

TOP NEWS: Centrica And easyJet Bumped From FTSE 100 For Avast And GVC

TOP NEWS: Centrica And easyJet Bumped From FTSE 100 For Avast And GVC

Read more
1 Jun 2020 12:02

UK EXECUTIVE CHANGE SUMMARY: Rambler Metals & Minerals Picks New CEO

UK EXECUTIVE CHANGE SUMMARY: Rambler Metals & Minerals Picks New CEO

Read more
1 Jun 2020 07:43

UPDATE 2-AstraZeneca scores twin drug approvals alongside vaccine progress

* Lynparza gains CHMP nod for advanced pancreatic cancer* Brilinta approved by FDA to cut risk of first heart attack* Coronavirus vaccine partner Oxford Biomedica appoints new chair (Writes through, adds detail, context)June 1 (Reuters) - Britain's...

Read more
28 May 2020 12:41

Oxford Biomedica Pens Virus Vaccine Supply Deal With AstraZeneca

Oxford Biomedica Pens Virus Vaccine Supply Deal With AstraZeneca

Read more
14 May 2020 09:19

UK BROKER RATINGS SUMMARY: Berenberg Raises HSBC To Hold From Sell

UK BROKER RATINGS SUMMARY: Berenberg Raises HSBC To Hold From Sell

Read more
6 May 2020 15:07

Oxford Biomedica Sinks To Loss In 2019 But Remains Optimistic

Oxford Biomedica Sinks To Loss In 2019 But Remains Optimistic

Read more
6 May 2020 12:52

Oxford Biomedica swings to loss as licensing revenue falls

(Sharecast News) - Gene and cell therapy company Oxford Biomedica reported an improvement in bioprocessing and commercial development revenues to ?47.3m in its preliminary results on Wednesday, from ?40.5m.

Read more
29 Apr 2020 16:13

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
28 Apr 2020 11:13

Liberum hikes target price on Oxford Biomedica

(Sharecast News) - Analysts at Liberum hiked their target price on gene and cell therapy company Oxford BioMedica from £8.60 per share to £10.90 on Tuesday, citing demand at its new OxBox manufacturing facility.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.